Skip to content

Wearable Robotic Functional Assistance for Stroke Rehabilitation

Wearable Robotic Functional Assistance for Stroke Rehabilitation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00396708
Enrollment
20
Registered
2006-11-07
Start date
2006-08-31
Completion date
Unknown
Last updated
2010-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CVA (Cerebrovascular Accident)

Keywords

Robotics, Rehabilitation, Arm, Stroke, Weakness, Outpatient, Chronic

Brief summary

This study aims to evaluate the effectiveness of using the myomo e100 wearable robotic rehabilitation system for increasing functional independence and long term rehabilitation of chronic stroke victims with a hemiparetic upper extremity.

Detailed description

This is a case controlled study for evaluation of the effectiveness of using the myomo e100 wearable robotic rehabilitation for upper arm therapy following stroke. The intervention for the study will be for the control group- 6-8 weeks of therapeutic exercise and functional training for a total of 18 hours of intervention, or the case group- 6-8 weeks of therapeutic exercise and functional training with the use of the AJB for a total of 18 hours of intervention. Each session will be one hour in length. The length of the study and length of each session is per standard rehabilitation protocol that has been well documented in previous studies as well as the pilot study regarding the AJB. A pre and post test with a 3 month follow up of all measures will be included in the study. Study procedures will focus on performing functional tasks using the e100.

Interventions

DEVICEmyomo e100 neurorobotic elbow brace

Sponsors

Myomo
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Medically Stable * Cognitive Awareness * Weakness in upper arm * Over 1 year post CVA * not engaged in any other upper arm therapies

Exclusion criteria

* Rashes, open wounds or skin sensitivity on arm * Very high elbow tone (arm rigid in flexion or extension)

Design outcomes

Primary

MeasureTime frame
Motor Activity Log
Fugl-Meyer Upper Arm Function
Wolf Motor Function
SF-36 QOL Survey
Range of Motion
Muscle Strength Test

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026